Carson D S
Medical University of South Carolina, Charleston, USA.
J Am Pharm Assoc (Wash). 1996 Apr;NS36(4):234-242, 269.
Bone loss resulting from estrogen deficiency is the leading cause of osteoporosis in postmenopausal women. Oral and transdermal estrogen can prevent osteoporosis. For most women, the benefits of hormone replacement therapy (HRT) outweigh any risks that exist. The recurrence of vaginal bleeding is the most common reason that women discontinue HRT.
雌激素缺乏导致的骨质流失是绝经后女性骨质疏松症的主要原因。口服和经皮雌激素可预防骨质疏松症。对大多数女性而言,激素替代疗法(HRT)的益处超过任何现存风险。阴道出血复发是女性停止激素替代疗法最常见的原因。